TuHURA Biosciences, Inc.

HURA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001498382

SEC filings (opens in a new tab)

No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 11, 2026: $96.9M
Insider buysOpen market, last 90 days: 0
Insider sellsOpen market, last 90 days: 0
13F holdersQ2 2026, +2 vs. previous quarter: 89
13F valueReported value at the end of Q2 2026: $21.0M
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2026: $0; No comparable prior period
Net income, FY2026: -$30.1M; No comparable prior period
Free cash flow, FY2026: -$27.7M; No comparable prior period
Revenue, Q2 FY2027: –; No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 6.20M; Shares sold short
Change: +265.5K; +4.5% vs. previous
Days to cover: 12.63; At average daily volume

Superinvestors holding HURA, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HURA at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by TuHURA Biosciences, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Feb 17, 2022 (view filing)4:00 PM ET	Feb 15	2 days	Hoffman RobertPresident and CEO	PPurchase	+55.0K	$0.469	+$25.8K	New position55.0K after
Dec 9, 2021 (view filing)	Dec 8	1 day	Praill Anthony ScottChief Financial Officer	PPurchase	+28.7K	$0.68	+$19.5K	+338.2%37.2K after
Dec 8, 2021 (view filing)	Dec 6-7	2 days	Zarrabian SaiidHead of Strategic Partnerships	PPurchase	+50.0K	$0.6281	+$31.4K	+909.1%55.5K after	2 lots
Nov 24, 2021 (view filing)	Nov 22	2 days	Johnson Laura L.Director	PPurchase	+3.00K	$0.74	+$2.22K	New position3.00K after

Top 10 13F holders, Q2 2026

See all 89 holders

The largest institutional positions in TuHURA Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding HURA in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Vanguard Capital Management LLC	2,267,901	$5.31M	0.00%	+193,673+9.3%	Added
Northern Trust Corp	1,621,042	$3.79M	0.00%	+1,322,855+443.6%	Added
BlackRock, Inc.	690,088	$1.61M	0.00%	−1,760,168−71.8%	Reduced
Geode Capital Management, LLC	484,219	$1.13M	0.00%	−502,703−50.9%	Reduced
Millennium Management LLC	454,535	$1.06M	0.00%	+454,535	New
AQR Capital Management LLC	424,600	$993.6K	0.00%	−182,568−30.1%	Reduced
Vanguard Fiduciary Trust Co	251,186	$587.8K	0.00%	−35,947−12.5%	Reduced
Citadel Advisors LLC	232,319	$543.6K	0.00%	+232,319	New
State Street Corp	188,404	$440.9K	0.00%	−324,509−63.3%	Reduced
Jane Street Group, LLC	163,891	$383.5K	0.00%	+163,891	New

Holders of 5% or more of HURA

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of TuHURA Biosciences, Inc..

Largest holders of HURA from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Highbridge Capital Management LLC	13G	9.10%6.06M shares	New	Feb 17, 20261 filing	Feb 17, 2026	SEC

Politician trades

All politician trades in HURA

1 member of Congress reported 3 trades in TuHURA Biosciences, Inc. since 2020. Newest filings:

Latest politician trades in HURA
Filed	Politician	Type	Amount
Aug 9, 2025	Laurel M. Lee House · FL	Buy	$50K-$100K
Jan 7, 2025	Laurel M. Lee House · FL	Buy	$1K-$15K
Nov 21, 2024	Laurel M. Lee House · FL	Exchange	$100K-$250K

Laurel M. Lee
House · FL · Aug 9, 2025
Buy$50K-$100K
Laurel M. Lee
House · FL · Jan 7, 2025
Buy$1K-$15K
Laurel M. Lee
House · FL · Nov 21, 2024
Exchange$100K-$250K